ATE410691T1 - Verwendung des proteins proteasome aktivator untereinheit 3 als marker für kolorektale karzinome - Google Patents

Verwendung des proteins proteasome aktivator untereinheit 3 als marker für kolorektale karzinome

Info

Publication number
ATE410691T1
ATE410691T1 AT04741385T AT04741385T ATE410691T1 AT E410691 T1 ATE410691 T1 AT E410691T1 AT 04741385 T AT04741385 T AT 04741385T AT 04741385 T AT04741385 T AT 04741385T AT E410691 T1 ATE410691 T1 AT E410691T1
Authority
AT
Austria
Prior art keywords
protein
subunity
marker
colorectal carcinoma
proteasome activator
Prior art date
Application number
AT04741385T
Other languages
English (en)
Inventor
Michael Tacke
Peter Berndt
Marie-Luise Hagmann
Johann Karl
Hanno Langen
Stefan Palme
Markus Roessler
Wolfgang Rollinger
Werner Zolg
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Application granted granted Critical
Publication of ATE410691T1 publication Critical patent/ATE410691T1/de

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57535—Immunoassay; Biospecific binding assay; Materials therefor for cancer of the large intestine, e.g. colon, rectum or anus

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Food Science & Technology (AREA)
  • Biochemistry (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
AT04741385T 2003-08-08 2004-08-06 Verwendung des proteins proteasome aktivator untereinheit 3 als marker für kolorektale karzinome ATE410691T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP03017582 2003-08-08

Publications (1)

Publication Number Publication Date
ATE410691T1 true ATE410691T1 (de) 2008-10-15

Family

ID=34130056

Family Applications (1)

Application Number Title Priority Date Filing Date
AT04741385T ATE410691T1 (de) 2003-08-08 2004-08-06 Verwendung des proteins proteasome aktivator untereinheit 3 als marker für kolorektale karzinome

Country Status (9)

Country Link
US (1) US20060199232A1 (de)
EP (1) EP1654538B1 (de)
JP (1) JP4282087B2 (de)
CN (1) CN1833170B (de)
AT (1) ATE410691T1 (de)
CA (1) CA2530479C (de)
DE (1) DE602004017017D1 (de)
ES (1) ES2315673T3 (de)
WO (1) WO2005015228A1 (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2876625B1 (fr) † 2004-10-19 2008-08-08 Alsacienne D Aluminium Sa Soc Film d'emballage multicouche metalloplastique
US10815517B2 (en) * 2009-04-28 2020-10-27 Roche Diagnostics Operations, Inc. Use of DPPIV/seprase as a marker for cancer

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU762373B2 (en) * 1998-10-20 2003-06-26 Millennium Pharmaceuticals, Inc. Method for monitoring proteasome inhibitor drug action
CA2410480A1 (en) * 2000-05-26 2001-12-06 Board Of Trustees Of The University Of Illinois Reagents and methods for identifying and modulating expression of genes regulated by retinoids

Also Published As

Publication number Publication date
CA2530479C (en) 2010-01-19
CA2530479A1 (en) 2005-02-17
EP1654538A1 (de) 2006-05-10
JP2007501386A (ja) 2007-01-25
US20060199232A1 (en) 2006-09-07
ES2315673T3 (es) 2009-04-01
CN1833170B (zh) 2011-07-06
CN1833170A (zh) 2006-09-13
JP4282087B2 (ja) 2009-06-17
DE602004017017D1 (de) 2008-11-20
WO2005015228A1 (en) 2005-02-17
EP1654538B1 (de) 2008-10-08

Similar Documents

Publication Publication Date Title
ATE471512T1 (de) Verwendung des proteins s100a 12 als marker für kolorektalkarzinom
KR100711046B1 (ko) 대장암에 대한 마커로서의 니코틴아미드ｎ―메틸트랜스퍼라아제의 용도
ATE554389T1 (de) Apex als marker für lungenkrebs
DE60300339D1 (de) Verfahren zum Nachweis von Karzinomen in solubilisierten zervikalen Körperproben
MX2010000971A (es) Sistema y metodos que determinan concentracion de analito utilizando amperometria resuelta en tiempo.
CY1112553T1 (el) Ανοσοπροσδιορισμοι υψηλης ευαισθησιας και κιτια για τον προσδιορισμο πεπτιδιων και πρωτεϊνων βιολογικου ενδιαφεροντος
CA2701341A1 (en) Method of assessing colorectal cancer from a stool sample by use of the marker combination calprotectin and hemoglobin/haptoglobin complex
WO2005124356A3 (en) Use of protein cbp2 as a marker for colorectal cancer
ATE430936T1 (de) Verwendung von cyfra 21-1 und osteopontin als marker für kolorektalkarzinome
DE602007006671D1 (de) Verwendung von nnmt als marker für lungenkrebs
DE60325382D1 (de) Verfahren zur diagnose von gebärmutterhalskrebs
DE602004017317D1 (de) Verwendung der proteine proteinase 3 (prn3) und leukozyten elastatse inhibitor (ileu) als marker für kolorektale karzinome
DK2038430T3 (da) Toll-Like-Receptor-4-dysfunktion og de biologiske anvendelser deraf
ATE503846T1 (de) Verfahren zur diagnose eines ovarialkarzinoms
ATE353544T1 (de) Verwendung des proteins masp als marker für kolorektale karzinome
ATE534037T1 (de) Verwendung des proteins asc als marker für brustkrebs
ATE333521T1 (de) Detektion von vancomycin-resistenten enterococcus-subspezies
ATE359516T1 (de) Verwendung des proteins crabp ii (cellular retinoic acid-binding protein ii) als marker für brustkrebs
ATE426168T1 (de) Verwendung von asc als marker fur kolorektalkarzinome
ATE383418T1 (de) Verfahren und zusammensetzungen zur bestimmung glycierter proteine
ATE393393T1 (de) Verwendung des proteins spee als marker für brustkrebs
DE602004017017D1 (de) Verwendung des proteins proteasome aktivator untereinheit 3 als marker für kolorektale karzinome
ATE418737T1 (de) Verwendung des proteins spermidinsynthase (spee) als marker für kolorektalkarzinom
ATE500505T1 (de) Enzymhemmungsimmunverfahren
FR2894675B1 (fr) Distinction des meningites bacteriennes et virales

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1654538

Country of ref document: EP